Abstract
Key Clinical Message
Tardive dystonia is a risk factor in medical antipsychotic treatment. It often
begins with repetitive involuntary jaw and tongue movements resulting in
impaired chewing and detrimental effect on the dentition. The orofacial dysfunction
may go unrecognized in a neurological setting. The diagnosis may be
difficult so we suggest interdisciplinary collaboration.
Tardive dystonia is a risk factor in medical antipsychotic treatment. It often
begins with repetitive involuntary jaw and tongue movements resulting in
impaired chewing and detrimental effect on the dentition. The orofacial dysfunction
may go unrecognized in a neurological setting. The diagnosis may be
difficult so we suggest interdisciplinary collaboration.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Clinical Case Reports |
| Vol/bind | 6 |
| Udgave nummer | 11 |
| Sider (fra-til) | 2150-2155 |
| Antal sider | 6 |
| ISSN | 2050-0904 |
| DOI | |
| Status | Udgivet - 2018 |
Emneord
- Det Sundhedsvidenskabelige Fakultet
- Antipsychotics, botulinum toxin, bruxism, masticatory muscles, tardive dystonia